Undecanoate 250

Testosterone Undecanoate 250mg/ml — Undecanoate 250 by Dragon Pharma

Undecanoate 250 is Dragon Pharma's formulation of Testosterone Undecanoate at 250mg/ml — the longest-ester injectable testosterone available, with an approximately 20-21 day half-life that enables the least frequent injection schedule of any testosterone formulation. Known pharmaceutically as Nebido (Bayer, 1000mg/4ml) for TRT, the injectable undecanoate ester is the preferred formulation for testosterone replacement therapy in many European countries precisely because its extreme duration allows injections every 10-14 weeks in clinical TRT. For performance use, the long half-life creates specific advantages and significant considerations around PCT timing.

Also searched as: Testosterone Undecanoate, Undecanoate 250, Nebido injectable, long ester testosterone, Dragon Pharma Undecanoate.

The Undecanoate Ester — Why It's Different from All Other Testosterone Esters

The Undecanoate ester is categorically longer than any other testosterone ester in the Dragon Pharma range:

The Undecanoate ester's 11-carbon chain is the longest attached to any injectable testosterone — producing a half-life nearly three times that of Enanthate and nearly ten times that of Propionate. The ester accounts for approximately 37% of the molecule's molecular weight, meaning 250mg of Testosterone Undecanoate contains approximately 157mg of actual testosterone after ester cleavage.

The Nebido Context — Clinical TRT Application

Understanding Undecanoate's clinical use helps frame its performance application:

• Nebido (Bayer HealthCare) is the branded pharmaceutical Testosterone Undecanoate injection — 1000mg in 4ml castor oil — approved and widely prescribed across Europe, Australia and many Asian countries for male hypogonadism TRT
• The clinical TRT protocol: loading injection at week 0, second injection at week 6 (to rapidly establish stable levels), then every 10-14 weeks thereafter — typically only 4-5 injections per year for full testosterone replacement
• This extremely infrequent injection schedule is Nebido's primary clinical advantage over weekly or twice-weekly Enanthate/Cypionate injections — improving patient compliance significantly
• Dragon Pharma's Undecanoate 250 at 250mg/ml in a 10ml vial provides the same pharmaceutical compound in a different format — higher concentration and larger volume, suited to the performance context where higher doses may be used more frequently than clinical TRT

Performance Use — Advantages and Considerations

For performance users, Testosterone Undecanoate's pharmacokinetics create specific trade-offs:

• Advantages: Fewest injections of any testosterone — every 2-4 weeks for performance doses; extremely stable blood levels once steady state is reached (minimal peak-to-trough variation); less injection site management than weekly or twice-weekly protocols
• Disadvantage — slow onset: Testosterone Undecanoate reaches meaningful blood levels slowly — peak concentration from a single injection is reached at approximately 7-10 days, with steady state requiring multiple injections over many weeks. Unlike Propionate or even Enanthate, there is no meaningful "fast kick" — users typically wait 3-4 weeks before experiencing full effects
• Major disadvantage — PCT delay: The ~21-day half-life means the compound is still substantially active 3-4 weeks after the last injection. PCT cannot begin until 4-6 weeks post last injection — substantially longer than Enanthate (2-3 weeks) or Propionate (3-5 days). For longer cycles, this extends the total suppression period considerably
• Dose adjustment inflexibility: If side effects emerge, the effect of a dose change takes 2-3 weeks to manifest in changed blood levels — unlike short esters where daily adjustment has near-immediate effect

Effects and Benefits

• Full testosterone pharmacological profile — all anabolic, androgenic, libido, mood and erythropoietic effects of testosterone
• Fewest injections of any injectable testosterone — every 2-4 weeks for performance doses
• Extremely stable blood levels at steady state — the long half-life produces minimal peak-to-trough variation between injections
• Clinical-grade compound — same active substance as prescription Nebido
• Aromatisation to estradiol — AI management required as with all testosterone formulations

Dosage and Administration

At 250mg/ml, a 2ml injection delivers 500mg; a 4ml injection delivers 1,000mg. Castor oil carrier is viscous — use a larger gauge needle for drawing (21g) and a standard 23g for injection. Inject intramuscularly in the gluteal muscle for volumes above 2ml. Estrogen management with Arimidex or Aromasin is required — aromatisation occurs at the same rate as with any testosterone. PCT begins 4-6 weeks after the last injection.